If UCHL1 methylation is RCC-related, detection of UCHL1 DNA promoter methylation in addition to the existence of UCHL1-specific autoantibodies detected in sera of tumor patients [46,55,56] may further help to define patients with poor prognosis. This evidence concerns the gene UCHL1 and neoplasm.